Starget Pharma

United States · Biotech · Healthtech · AI · Enterprise software

Develops next-generation peptide radioligand therapies for cancer

Funding history

1 round · 1 with disclosed amounts
AnnouncedRoundAmountInvestors
Series A$18MBRF — Role not disclosedCancer Focus Fund — Role not disclosedIlex Medical — Role not disclosedLouisiana Growth Fund — Role not disclosed
Sourcesstargetpharma.com ↗